Journal
CLINICS IN LABORATORY MEDICINE
Volume 41, Issue 2, Pages 309-324Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cll.2021.03.009
Keywords
Mass spectrometry imaging; MALDI; Cancer; Infectious disease; Drug distribution; Clinical
Categories
Funding
- National Institutes of Health/National Cancer Institute (NIH/NCI) [R01CA201469, U54CA210180]
- Breast Cancer Research Foundation
- Ferenc Jolesz National Center for Image Guided Therapy at BWH [P41 EB015898]
Ask authors/readers for more resources
Mass spectrometry imaging is an emerging analytical technique that uses a mass spectrometer to analyze targets in at least two spatial dimensions while preserving the relative spatial location of molecules during analysis.
Mass spectrometry imaging (MSI) is an emerging set of analytical techniques that hold promise in changing pathology and tissue-based diagnostics.1 In its simplest sense, MSI is an analytical chemistry application in which a target is analyzed using a mass spectrometer in at least 2 spatial dimensions and, in doing so, preserves the relative spatial location of molecules during analysis. The net effect is the creation
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available